查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1916511

全球DNA定序市場：市場規模、佔有率、成長率、產業分析、按類型、應用和地區劃分的分析及預測（2026-2034）

DNA Sequencing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 請詢問到貨日

價格

DNA定序市場成長驅動因素

全球DNA定序市場是現代基因組學的關鍵基礎，能夠精確識別核酸序列，用於疾病診斷、藥物研發、個人化醫療、法醫學和演化研究。 DNA定序技術已從第一代桑格定序發展到下一代定序（NGS）和先進的第三代定序（TGS）平台，這些平台具有高通量、長讀長和高精度等優勢。這些進步拓展了定序的應用範圍，包括臨床診斷、腫瘤學、罕見疾病檢測和群體基因體學研究。

DNA定序市場規模及價值

根據市場報告顯示，2025年全球DNA定序市場規模為123.1億美元。預計到2026年，在診斷和實驗室中測序技術日益普及的推動下，該市場規模將增長至133.6億美元。在預測期內，預計到2034年，該市場規模將達到272.5億美元，反映了定序技術快速融入常規臨床工作流程和藥物研發流程。預計2026年至2034年，該市場將以9.32%的複合年增長率成長，這主要得益於技術創新、監管批准以及基因組數據臨床應用價值的不斷提升。

推動市場成長的因素

全基因組定序（WGS）在臨床診斷中的日益普及是推動市場成長的關鍵因素。全基因組定序 (WGS) 能夠全面檢測傳統方法難以發現的基因突變，從而支持早期診斷和標靶治療的選擇。隨著遺傳性疾病和癌症發生率的上升，人們越來越依賴基因組分析進行治療方案製定。

定序資料在藥物發現和生物標記識別的應用日益廣泛，進一步推動了市場需求。製藥公司越來越依賴基因組數據集進行患者分層、臨床試驗優化和治療標靶識別。公共和私人對基因組基礎設施、國家基因組圖譜規劃以及對基於二代測序 (NGS) 的診斷技術的監管支持的投資，正在加速其在臨床實踐中的應用。

市場限制因素與挑戰

一個關鍵的限制因素是全球基因組學和生物資訊學領域熟練專家的短缺。解讀定序資料需要專門的計算技能，這限制了其在資源有限的醫療保健系統中的應用。定序錯誤、假陽性以及重複基因組區域檢測不足等技術挑戰也會影響診斷的可靠性。

基因組資訊高度敏感，因此資料安全和隱私問題仍然是重大挑戰。缺乏標準化的全球基因組數據處理和跨境研究合作監管框架，進一步阻礙了市場擴張，尤其是在新興經濟體。

市場趨勢與技術進步

第三代定序平台發展勢頭強勁，這得益於其生成長讀長的能力，從而能夠準確檢測結構突變和表觀遺傳修飾。奈米孔定序和單分子即時定序技術正越來越多地應用於癌症研究、罕見疾病診斷和微生物組分析。

將人工智慧 (AI) 和機器學習應用於資料解讀正成為一大趨勢，幫助實驗室更有效率地分析大量資料集。基於雲端的生物資訊平台也在改善研究機構間的資料儲存、存取和協作。

液體活檢測序透過檢測循環腫瘤DNA實現非侵入性癌症監測，有助於早期發現並改善治療追蹤。

依產品/服務劃分的市場區隔

依產品/服務劃分，市場分為產品與軟體/服務兩部分。產品部分主要受定序儀、流動池和試劑盒的高需求驅動，預計2026年將佔據63.29%的市場。由於定序工作流程的重複採購週期，耗材預計將快速成長。

軟體/服務部分呈現顯著成長，這主要得益於定序服務外包的增加，尤其是在臨床和藥物研究領域，以及對生物資訊解決方案日益增長的需求。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家主要疾病流行情形（2025 年）
  • DNA 定序技術進展
  • 概述：DNA 定序新興趨勢
  • 主要公司新產品發布及核准狀況
  • 主要產業趨勢：併購、收購等等。
  • 新冠疫情對市場的影響

第五章 全球DNA定序市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品/服務劃分
    • 產品
      • 設備
      • 耗材
    • 軟體/服務
  • 市場分析、洞察與預測：依技術劃分
    • 桑格定序
    • 次世代定序
    • 第三代定序
  • 市場分析、洞察與預測：依類型劃分
    • 全基因組/外顯子定序
    • 表觀遺傳學
    • 標靶定序感測
    • 宏基因體學
    • 其他
  • 市場分析、洞察與預測：依應用領域劃分
    • 藥物發現與開發
    • 診斷
    • 個人化醫療
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 生技和製藥公司
    • 診斷中心
    • 學術和研究機構
    • 其他
  • 市場分析、洞察與預測：按地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美DNA定序市場分析：洞察與預測 （2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲DNA定序市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 其他歐洲國家

第八章：亞太地區DNA定序市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 印度
    • 日本
    • 韓國
    • 東南亞亞洲
    • 其他亞太地區

第九章：拉丁美洲DNA定序市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章：中東與非洲DNA定序市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會（GCC）國家
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 公司型材
    • Illumina 公司
    • 賽默飛世爾科技公司
    • 牛津奈米孔技術有限公司。
    • 太平洋生物
    • 凱傑
    • 珀金埃爾默公司
    • Azenta 美國公司
    • 華大基因
Product Code: FBI101527

Growth Factors of DNA sequencing Market

The global DNA sequencing market is a fundamental pillar of modern genomics, enabling precise identification of nucleotide sequences for disease diagnosis, drug development, personalized medicine, forensic science, and evolutionary research. DNA sequencing technologies have transitioned from first-generation Sanger sequencing to high-throughput Next-Generation Sequencing (NGS) and advanced Third-Generation Sequencing (TGS) platforms, offering rapid processing, long-read capabilities, and enhanced accuracy. These advancements have expanded sequencing applications across clinical diagnostics, oncology, rare disease detection, and population-scale genomics initiatives.

DNA Sequencing Market Size and Market Value

As per the market report, the global DNA sequencing market size was valued at USD 12.31 billion in 2025. The market is projected to grow to USD 13.36 billion in 2026, supported by rising adoption of sequencing technologies in diagnostics and research laboratories. Over the forecast period, the market is expected to reach a market value of USD 27.25 billion by 2034, reflecting rapid integration of sequencing into routine clinical workflows and pharmaceutical research pipelines. The market is projected to expand at a CAGR of 9.32% from 2026 to 2034, driven by technological innovation, regulatory approvals, and expanding clinical utility of genomic data.

Market Drivers Supporting Growth

The growing adoption of Whole Genome Sequencing (WGS) in clinical diagnostics is a major growth driver. WGS enables comprehensive detection of genetic variations that traditional methods often fail to identify, supporting early diagnosis and targeted therapy selection. Rising prevalence of genetic disorders and cancer is increasing reliance on genomic profiling for treatment planning.

Expanding use of sequencing data in drug discovery and biomarker identification is further driving demand. Pharmaceutical companies increasingly rely on genomic datasets for patient stratification, clinical trial optimization, and identification of therapeutic targets. Public and private investments in genomics infrastructure, national genome mapping programs, and regulatory support for NGS-based diagnostics are accelerating clinical integration.

Market Restraints and Challenges

A major restraint is the global shortage of skilled professionals in genomics and bioinformatics. Interpreting sequencing data requires specialized computational expertise, limiting adoption in resource-constrained healthcare systems. Technical challenges such as sequencing errors, false positives, and limitations in detecting repetitive genomic regions also affect diagnostic reliability.

Data security and privacy concerns remain critical, as genomic information is highly sensitive. Lack of standardized global regulatory frameworks for genomic data handling and cross-border research collaborations further complicates market expansion, especially in emerging economies.

Market Trends and Technological Advancements

Third-Generation Sequencing platforms are gaining strong momentum due to their ability to generate long reads, enabling accurate detection of structural variants and epigenetic modifications. Nanopore and Single-Molecule Real-Time sequencing are increasingly adopted in cancer research, rare disease diagnostics, and microbiome analysis.

Integration of artificial intelligence and machine learning in data interpretation is becoming a major trend, helping laboratories analyze massive datasets more efficiently. Cloud-based bioinformatics platforms are also improving data storage, accessibility, and collaboration across research institutions.

Liquid biopsy sequencing is gaining traction for non-invasive cancer monitoring by detecting circulating tumor DNA, improving early detection and treatment monitoring.

Segmentation Analysis by Products and Services

By products and services, the market is divided into products and software & services. The products segment dominated the market with a 63.29% share in 2026, driven by high demand for sequencing instruments, flow cells, and reagent kits. Consumables are expected to grow rapidly due to repeat purchase cycles associated with sequencing workflows.

The software and services segment is witnessing strong growth due to increasing outsourcing of sequencing services and demand for bioinformatics solutions, particularly in clinical and pharmaceutical research settings.

Segmentation by Technique and Type

By technique, Next-Generation Sequencing held the largest market share and is projected to capture 85.99% share in 2026, driven by its cost efficiency, scalability, and compatibility with multiple clinical applications. Third-Generation Sequencing is growing at the fastest pace due to long-read sequencing advantages, while Sanger sequencing remains relevant for validation and small-scale research.

By type, targeted sequencing dominated in 2024 due to its widespread use in oncology diagnostics. Whole genome and whole exome sequencing is expanding rapidly, with an estimated 45.98% market share in 2026, driven by rare disease diagnostics and population genomics studies. Epigenomics is growing rapidly due to rising cancer research applications.

Segmentation by Application and End User

By application, diagnostics leads the market, supported by growing cancer screening programs and genetic disorder testing. Drug discovery and development represents the second-largest segment, driven by genomics-guided clinical trials and biomarker research.

By end user, diagnostic centers dominate due to increasing adoption of NGS in oncology and prenatal screening. Academic and research institutes remain strong contributors through large-scale genome projects, while biotechnology and pharmaceutical companies continue expanding internal sequencing capabilities.

Regional Outlook

North America dominated the DNA sequencing market with USD 5.74 billion in 2025 and USD 6.21 billion in 2026, supported by advanced research infrastructure, strong reimbursement systems, and large multi-omics programs. The U.S. remains the largest national market due to extensive clinical sequencing adoption and biotechnology investments.

Europe follows with strong government funding, national genome initiatives, and rising cancer prevalence. Asia Pacific is the fastest-growing region due to expanding healthcare investments, government genomics programs, and domestic manufacturing partnerships in China, Japan, and India. Latin America and the Middle East & Africa are witnessing gradual growth supported by expanding diagnostic infrastructure.

Competitive Landscape

Major companies operating in the DNA sequencing market include Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies, PacBio, QIAGEN, PerkinElmer, Azenta, and BGI Genomics. These players focus on new platform launches, bioinformatics integration, geographic expansion, and strategic collaborations with healthcare and research institutions. Investments in long-read sequencing, automation, and AI-driven analytics remain central to competitive differentiation.

Conclusion

The DNA sequencing market is experiencing strong and sustained growth, driven by rapid technological advancements, expanding clinical applications, and increasing integration of genomics into routine healthcare and pharmaceutical research. With the market valued at USD 12.31 billion in 2025, projected to reach USD 13.36 billion in 2026, and expected to expand to USD 27.25 billion by 2034, the industry reflects robust long-term potential. Rising adoption of whole genome and targeted sequencing in oncology, rare disease diagnosis, and personalized medicine, along with growing use in drug discovery and biomarker development, is strengthening market demand. Although challenges such as shortage of skilled professionals, data interpretation complexity, and privacy concerns persist, continuous innovation in next-generation and third-generation sequencing platforms, integration of AI-driven bioinformatics, and expanding government-supported genomics initiatives are expected to further accelerate market adoption across developed and emerging regions.

Segmentation By Products & Services

  • Products
    • Equipment
    • Consumables
  • Software & Services

By Technique

  • Sanger Sequencing
  • Next-generation Sequencing
  • Third-generation Sequencing

By Type

  • Whole Genome / Exome Sequencing
  • Epigenomics
  • Targeted Sequencing
  • Metagenomics
  • Others

By Application

  • Drug Discovery & Development
  • Diagnostics
  • Personalized Medicine
  • Others

By End-user

  • Biotechnology & Pharmaceutical Companies
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others

By Region

  • North America (By Products & Services, Technique, Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Products & Services, Technique, Type, Application, End-user, and Country/ Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Products & Services, Technique, Type, Application, End-user, and Country/ Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Products & Services, Technique, Type, Application, End-user, and Country/ Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Products & Services, Technique, Type, Application, End-user, and Country/ Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Countries, 2025
  • 4.2. Technological Advancement in DNA Sequencing
  • 4.3. Overview: Emerging Trends in the DNA Sequencing
  • 4.4. New Product Launches/ Approvals, By Key Players
  • 4.5. Key Industry Developments- Mergers, Partnerships, Acquisitions, etc.
  • 4.6. Impact of COVID-19 on the Market

5. Global DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Products & Services
    • 5.1.1. Products
      • 5.1.1.1. Equipment
      • 5.1.1.2. Consumables
    • 5.1.2. Software & Services
  • 5.2. Market Analysis, Insights and Forecast - By Technique
    • 5.2.1. Sanger Sequencing
    • 5.2.2. Next-generation Sequencing
    • 5.2.3. Third-generation Sequencing
  • 5.3. Market Analysis, Insights and Forecast - By Type
    • 5.3.1. Whole Genome / Exome Sequencing
    • 5.3.2. Epigenetics
    • 5.3.3. Targeted Sequencing
    • 5.3.4. Metagenomics
    • 5.3.5. Others
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Drug Discovery & Development
    • 5.4.2. Diagnostics
    • 5.4.3. Personalized Medicine
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By End-user
    • 5.5.1. Biotechnology & Pharmaceutical Companies
    • 5.5.2. Diagnostics Centers
    • 5.5.3. Academic & Research Institutes
    • 5.5.4. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Products & Services
    • 6.1.1. Products
      • 6.1.1.1. Equipment
      • 6.1.1.2. Consumables
    • 6.1.2. Software & Services
  • 6.2. Market Analysis, Insights and Forecast - By Technique
    • 6.2.1. Sanger Sequencing
    • 6.2.2. Next-generation Sequencing
    • 6.2.3. Third-generation Sequencing
  • 6.3. Market Analysis, Insights and Forecast - By Type
    • 6.3.1. Whole Genome / Exome Sequencing
    • 6.3.2. Epigenetics
    • 6.3.3. Targeted Sequencing
    • 6.3.4. Metagenomics
    • 6.3.5. Others
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Drug Discovery & Development
    • 6.4.2. Diagnostics
    • 6.4.3. Personalized Medicine
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By End-user
    • 6.5.1. Biotechnology & Pharmaceutical Companies
    • 6.5.2. Diagnostics Centers
    • 6.5.3. Academic & Research Institutes
    • 6.5.4. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Products & Services
    • 7.1.1. Products
      • 7.1.1.1. Equipment
      • 7.1.1.2. Consumables
    • 7.1.2. Software & Services
  • 7.2. Market Analysis, Insights and Forecast - By Technique
    • 7.2.1. Sanger Sequencing
    • 7.2.2. Next-generation Sequencing
    • 7.2.3. Third-generation Sequencing
  • 7.3. Market Analysis, Insights and Forecast - By Type
    • 7.3.1. Whole Genome / Exome Sequencing
    • 7.3.2. Epigenetics
    • 7.3.3. Targeted Sequencing
    • 7.3.4. Metagenomics
    • 7.3.5. Others
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Drug Discovery & Development
    • 7.4.2. Diagnostics
    • 7.4.3. Personalized Medicine
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By End-user
    • 7.5.1. Biotechnology & Pharmaceutical Companies
    • 7.5.2. Diagnostics Centers
    • 7.5.3. Academic & Research Institutes
    • 7.5.4. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.6.1. Germany
    • 7.6.2. U.K.
    • 7.6.3. France
    • 7.6.4. Italy
    • 7.6.5. Spain
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Products & Services
    • 8.1.1. Products
      • 8.1.1.1. Equipment
      • 8.1.1.2. Consumables
    • 8.1.2. Software & Services
  • 8.2. Market Analysis, Insights and Forecast - By Technique
    • 8.2.1. Sanger Sequencing
    • 8.2.2. Next-generation Sequencing
    • 8.2.3. Third-generation Sequencing
  • 8.3. Market Analysis, Insights and Forecast - By Type
    • 8.3.1. Whole Genome / Exome Sequencing
    • 8.3.2. Epigenetics
    • 8.3.3. Targeted Sequencing
    • 8.3.4. Metagenomics
    • 8.3.5. Others
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Drug Discovery & Development
    • 8.4.2. Diagnostics
    • 8.4.3. Personalized Medicine
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By End-user
    • 8.5.1. Biotechnology & Pharmaceutical Companies
    • 8.5.2. Diagnostics Centers
    • 8.5.3. Academic & Research Institutes
    • 8.5.4. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Products & Services
    • 9.1.1. Products
      • 9.1.1.1. Equipment
      • 9.1.1.2. Consumables
    • 9.1.2. Software & Services
  • 9.2. Market Analysis, Insights and Forecast - By Technique
    • 9.2.1. Sanger Sequencing
    • 9.2.2. Next-generation Sequencing
    • 9.2.3. Third-generation Sequencing
  • 9.3. Market Analysis, Insights and Forecast - By Type
    • 9.3.1. Whole Genome / Exome Sequencing
    • 9.3.2. Epigenetics
    • 9.3.3. Targeted Sequencing
    • 9.3.4. Metagenomics
    • 9.3.5. Others
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Drug Discovery & Development
    • 9.4.2. Diagnostics
    • 9.4.3. Personalized Medicine
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By End-user
    • 9.5.1. Biotechnology & Pharmaceutical Companies
    • 9.5.2. Diagnostics Centers
    • 9.5.3. Academic & Research Institutes
    • 9.5.4. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Products & Services
    • 10.1.1. Products
      • 10.1.1.1. Equipment
      • 10.1.1.2. Consumables
    • 10.1.2. Software & Services
  • 10.2. Market Analysis, Insights and Forecast - By Technique
    • 10.2.1. Sanger Sequencing
    • 10.2.2. Next-generation Sequencing
    • 10.2.3. Third-generation Sequencing
  • 10.3. Market Analysis, Insights and Forecast - By Type
    • 10.3.1. Whole Genome / Exome Sequencing
    • 10.3.2. Epigenetics
    • 10.3.3. Targeted Sequencing
    • 10.3.4. Metagenomics
    • 10.3.5. Others
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Drug Discovery & Development
    • 10.4.2. Diagnostics
    • 10.4.3. Personalized Medicine
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By End-user
    • 10.5.1. Biotechnology & Pharmaceutical Companies
    • 10.5.2. Diagnostics Centers
    • 10.5.3. Academic & Research Institutes
    • 10.5.4. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Illumina, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Thermo Fisher Scientific Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Oxford Nanopore Technologies plc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. PacBio
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. QIAGEN
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. PerkinElmer Inc.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Azenta US, Inc,
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. BGI Genomics
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
  • Table 2: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 3: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Technique 2021-2034
  • Table 4: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 5: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 6: Global DNA Sequencing Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 7: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Region 2021-2034
  • Table 8: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
  • Table 9: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 10: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 11: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 12: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 13: North America DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 14: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 15: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
  • Table 16: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 17: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 18: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 19: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 20: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 21: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
  • Table 23: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 24: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 25: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 26: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 27: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 28: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 29: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
  • Table 30: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 31: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 32: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 33: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 34: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 35: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
  • Table 37: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 38: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 39: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 40: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 41: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 42: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global DNA Sequencing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
  • Figure 3: Global DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 4: Global DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 5: Global DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 6: Global DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 7: Global DNA Sequencing Market Value (USD billion), by Region, 2025 & 2034
  • Figure 8: North America DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
  • Figure 9: North America DNA Sequencing Market Value Share (%), by Products & Services, 2025
  • Figure 10: North America DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 11: North America DNA Sequencing Market Value Share (%), by Technique, 2025
  • Figure 12: North America DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 13: North America DNA Sequencing Market Value Share (%), by Type, 2025
  • Figure 14: North America DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 15: North America DNA Sequencing Market Value Share (%), by Application, 2025
  • Figure 16: North America DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 17: North America DNA Sequencing Market Value Share (%), by End-user, 2025
  • Figure 18: North America DNA Sequencing Market Value (USD billion), By Country, 2025 & 2034
  • Figure 19: North America DNA Sequencing Market Value Share (%), By Country, 2025
  • Figure 20: Europe DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
  • Figure 21: Europe DNA Sequencing Market Value Share (%), by Products & Services, 2025
  • Figure 22: Europe DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 23: Europe DNA Sequencing Market Value Share (%), by Technique, 2025
  • Figure 24: Europe DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 25: Europe DNA Sequencing Market Value Share (%), by Type, 2025
  • Figure 26: Europe DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 27: Europe DNA Sequencing Market Value Share (%), by Application, 2025
  • Figure 28: Europe DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 29: Europe DNA Sequencing Market Value Share (%), by End-user, 2025
  • Figure 30: Europe DNA Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe DNA Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
  • Figure 33: Asia Pacific DNA Sequencing Market Value Share (%), by Products & Services, 2025
  • Figure 34: Asia Pacific DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 35: Asia Pacific DNA Sequencing Market Value Share (%), by Technique, 2025
  • Figure 36: Asia Pacific DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 37: Asia Pacific DNA Sequencing Market Value Share (%), by Type, 2025
  • Figure 38: Asia Pacific DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 39: Asia Pacific DNA Sequencing Market Value Share (%), by Application, 2025
  • Figure 40: Asia Pacific DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 41: Asia Pacific DNA Sequencing Market Value Share (%), by End-user, 2025
  • Figure 42: Asia Pacific DNA Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific DNA Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 44: Latin America DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
  • Figure 45: Latin America DNA Sequencing Market Value Share (%), by Products & Services, 2025
  • Figure 46: Latin America DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 47: Latin America DNA Sequencing Market Value Share (%), by Technique, 2025
  • Figure 48: Latin America DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 49: Latin America DNA Sequencing Market Value Share (%), by Type, 2025
  • Figure 50: Latin America DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 51: Latin America DNA Sequencing Market Value Share (%), by Application, 2025
  • Figure 52: Latin America DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 53: Latin America DNA Sequencing Market Value Share (%), by End-user, 2025
  • Figure 54: Latin America DNA Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America DNA Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
  • Figure 57: Middle East & Africa DNA Sequencing Market Value Share (%), by Products & Services, 2025
  • Figure 58: Middle East & Africa DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 59: Middle East & Africa DNA Sequencing Market Value Share (%), by Technique, 2025
  • Figure 60: Middle East & Africa DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 61: Middle East & Africa DNA Sequencing Market Value Share (%), by Type, 2025
  • Figure 62: Middle East & Africa DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 63: Middle East & Africa DNA Sequencing Market Value Share (%), by Application, 2025
  • Figure 64: Middle East & Africa DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 65: Middle East & Africa DNA Sequencing Market Value Share (%), by End-user, 2025
  • Figure 66: Middle East & Africa DNA Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa DNA Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 68: Global DNA Sequencing Market Share (%), By Company, 2025